SIM-0686

N/A

Report date: 2025/04/09 14:18:52

Base Information

Drug NameSIM-0686
Drug Alias NameSIM-0686SCR-A002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionFibroblast growth factor receptor 2 inhibitors
TargetsFibroblast growth factor receptor 2
Therapy Area/IndicationsSolid tumoursNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHainan Xiansheng Re Ming Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHainan Xiansheng Re Ming Pharmaceutical Co LtdShanghai Xiansheng Zaiming Pharmaceutical Biotechnology Co LtdJiangsu Simcere Pharmaceutical Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm Metastasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A